(Q44241545)

1 December 2017

title

Use of GnRH antagonists in the treatment of endometriosis (English)

1 reference

1 December 2017

1 reference

W Küpker

1

1 reference

1 December 2017

R E Felberbaum

2

1 reference

1 December 2017

M Krapp

3

1 reference

1 December 2017

T Schill

4

1 reference

1 December 2017

E Malik

5

1 reference

1 December 2017

K Diedrich

6

1 reference

1 December 2017

language of work or name

1 reference

1 July 2002

1 reference

Reproductive BioMedicine Online

1 December 2017

published in

1 reference

1 December 2017

volume

5

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

12-16

1 reference

Revised American Society for Reproductive Medicine classification of endometriosis: 1996

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Effects of triptorelin versus placebo on the symptoms of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Paracrine changes in the peritoneal environment of women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961590-8

7 January 2021

10.1016/S1472-6483(10)61590-8

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ojrzhcez2jdpjpa2t3u6zawddu

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ojrzhcez2jdpjpa2t3u6zawddu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ojrzhcez2jdpjpa2t3u6zawddu

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/ojrzhcez2jdpjpa2t3u6zawddu

1 reference

30 July 2022